Citations (48)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Rohini Kharwade, Nilesh Mahajan, Sachin More, Amol Warokar, Sachin Mendhi, Akshay Dhobley & Devendra Palve. (2023) Effect of PEGylation on drug uptake, biodistribution, and tissue toxicity of efavirenz–ritonavir loaded PAMAM G4 dendrimers. Pharmaceutical Development and Technology 28:2, pages 200-218.
Read now
Read now
Flavio De Maio, Valentina Palmieri, Marco De Spirito, Giovanni Delogu & Massimiliano Papi. (2019) Carbon nanomaterials: a new way against tuberculosis. Expert Review of Medical Devices 16:10, pages 863-875.
Read now
Read now
Nithya Ramesh & Abul Kalam Azad Mandal. (2019) Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model. Drug Development and Industrial Pharmacy 45:9, pages 1506-1514.
Read now
Read now
Jagdeep Singh, Tarun Garg, Goutam Rath & Amit K. Goyal. (2016) Advances in nanotechnology-based carrier systems for targeted delivery of bioactive drug molecules with special emphasis on immunotherapy in drug resistant tuberculosis – a critical review. Drug Delivery 23:5, pages 1676-1698.
Read now
Read now
Amit B Shirode, Dhruba J Bharali, Sameera Nallanthighal, Justin K Coon, Shaker A Mousa & Ramune Reliene. (2015) Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention. International Journal of Nanomedicine 10, pages 475-484.
Read now
Read now
Sanaul Mustafa, Roopa S. Pai, Gurinder Singh & V. Kusum Devi. (2015) Nanocarrier-based interventions for the management of MDR/XDR-TB. Journal of Drug Targeting 23:4, pages 287-304.
Read now
Read now
Gaurav Kumar, Samir Malhotra, Nusrat Shafiq, Promila Pandhi, Gopal Krishan Khuller & Sadhna Sharma. (2011) In vitro physicochemical characterization and short term in vivo tolerability study of ethionamide loaded PLGA nanoparticles: potentially effective agent for multidrug resistant tuberculosis. Journal of Microencapsulation 28:8, pages 717-728.
Read now
Read now
Articles from other publishers (41)
Simpal Kumar Suman, Natarajan Chandrasekaran & C. George Priya Doss. (2023) Micro-nanoemulsion and nanoparticle-assisted drug delivery against drug-resistant tuberculosis: recent developments. Clinical Microbiology Reviews.
Crossref
Crossref
Priyanka Maurya, Ravi Saklani, Samipta Singh, Raquibun Nisha, Nidhi Mishra, Priya Singh, Ravi Raj Pal, Abhiram Kumar, Manish K Chourasia & Shubhini A Saraf. (2022) Effective uptake of folate-functionalized ethionamide-loaded hybrid system: targeting alveolar macrophages. Nanomedicine 17:24, pages 1819-1831.
Crossref
Crossref
Liqun Shao, Shu Shen & Huan Liu. (2022) Recent advances in PLGA micro/nanoparticle delivery systems as novel therapeutic approach for drug-resistant tuberculosis. Frontiers in Bioengineering and Biotechnology 10.
Crossref
Crossref
Rohini Kharwade, Sachin More, Elizabeth Suresh, Amol Warokar, Nilesh Mahajan & Ujwala Mahajan. (2022) Improvement in Bioavailability and Pharmacokinetic Characteristics of Efavirenz with Booster Dose of Ritonavir in PEGylated PAMAM G4 Dendrimers. AAPS PharmSciTech 23:6.
Crossref
Crossref
Mani Sharma & Sakshi Kansal. 2022. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity. Contemporary Issues in Global Medicine and Moving Toward International Healthcare Equity
317
347
.
Deny Susanti, Nurul I. Aminudin, Mohamad W. Ismail, Muhammad Taher, Saiful A. Shafiee, Wan H. Danial & Nurasyikin Hamzah. 2022. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance. Emerging Nanomaterials and Nano-Based Drug Delivery Approaches to Combat Antimicrobial Resistance
365
394
.
Pooja Sanjay Khairnar, Ajit Singh & Rahul Shukla. 2022. Nanotechnology for Infectious Diseases. Nanotechnology for Infectious Diseases
387
417
.
Neelu Singh, Nidhi Mishra, Kaisar Raza & Poonam Parashar. 2022. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems. Pharmacokinetics and Pharmacodynamics of Nanoparticulate Drug Delivery Systems
333
346
.
Foteini Gkartziou, Nikolaos Giormezis, Iris Spiliopoulou & Sophia G. Antimisiaris. (2021) Nanobiosystems for Antimicrobial Drug-Resistant Infections. Nanomaterials 11:5, pages 1075.
Crossref
Crossref
V.N. Azger Dustachkeer, Christy Rosaline Nirmal, Sam Ebenezer Rajadas, Shainaba A. Saadhali, Silambuchelvi Kannayan & Vishnu Priya Padmanaban. 2021. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy. A Mechanistic Approach to Medicines for Tuberculosis Nanotherapy
149
173
.
Zsuzsa Baranyai, Héctor Soria‐Carrera, Maria Alleva, Ana C. Millán‐Placer, Ainhoa Lucía, Rafael Martín‐Rapún, José A. Aínsa & Jesús M. la Fuente. (2020) Nanotechnology‐Based Targeted Drug Delivery: An Emerging Tool to Overcome Tuberculosis. Advanced Therapeutics 4:1, pages 2000113.
Crossref
Crossref
Mohsen Tafaghodi, Farzad Khademi, Farideh shiehzadeh & Zohreh Firouzi. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
123
142
.
Damián Eduardo Pérez-Martínez & Roberto Zenteno-Cuevas. 2020. Nanotechnology Based Approaches for Tuberculosis Treatment. Nanotechnology Based Approaches for Tuberculosis Treatment
37
52
.
Josef Jampílek & Katarína Kráľová. 2020. Nanoformulations in Human Health. Nanoformulations in Human Health
469
502
.
Nithya Ramesh & Abul Kalam Azad Mandal. (2019) Encapsulation of epigallocatechin-3-gallate into albumin nanoparticles improves pharmacokinetic and bioavailability in rat model. 3 Biotech 9:6.
Crossref
Crossref
Afzal Hussain, Sima Singh, Sabya Sachi Das, Keshireddy Anjireddy, Subramanian Karpagam & Faiyaz Shakeel. (2019) Nanomedicines as Drug Delivery Carriers of Anti-Tubercular Drugs: From Pathogenesis to Infection Control. Current Drug Delivery 16:5, pages 400-429.
Crossref
Crossref
Yanping Cao, Zhihao Wei, Mengmeng Li, Haiyan Wang, Li Yin, Dongxiao Chen, Yanfei Wang, Yongchao Chen, Qi Yuan, Xiaohui Pu, Lanlan Zong & Shaofeng Duan. (2019) Formulation, Pharmacokinetic Evaluation and Cytotoxicity of an Enhanced- penetration Paclitaxel Nanosuspension. Current Cancer Drug Targets 19:4, pages 338-347.
Crossref
Crossref
Pratik Kulkarni, Deepak Rawtani & Tejas Barot. (2019) Formulation and optimization of long acting dual niosomes using Box-Behnken experimental design method for combinative delivery of Ethionamide and D-cycloserine in Tuberculosis treatment. Colloids and Surfaces A: Physicochemical and Engineering Aspects 565, pages 131-142.
Crossref
Crossref
Wenyi Gu, Valentin A. Bobrin, Sung-Po R. Chen, Zhao Wang, Jennifer P. Schoning, Yushu Gu, Weiyu Chen, Mingshui Chen, Zhongfan Jia & Michael J. Monteiro. (2018) Biodistribution of PNIPAM-Coated Nanostructures Synthesized by the TDMT Method. Biomacromolecules 20:2, pages 625-634.
Crossref
Crossref
Arunachalam Muthuraman. 2018. Nanostructures for the Engineering of Cells, Tissues and Organs. Nanostructures for the Engineering of Cells, Tissues and Organs
105
154
.
Sujit Kumar Debnath, Srinivasan Saisivam & Abdelwahab Omri. (2017) PLGA Ethionamide Nanoparticles for Pulmonary Delivery: Development and in vivo evaluation of dry powder inhaler. Journal of Pharmaceutical and Biomedical Analysis 145, pages 854-859.
Crossref
Crossref
Jitendra Wankar, Giuseppina Salzano, Elisabetta Pancani, Gabor Benkovics, Milo Malanga, Francesco Manoli, Ruxandra Gref, Eva Fenyvesi & Ilse Manet. (2017) Efficient loading of ethionamide in cyclodextrin-based carriers offers enhanced solubility and inhibition of drug crystallization. International Journal of Pharmaceutics 531:2, pages 568-576.
Crossref
Crossref
Mauro Cataldi, Chiara Vigliotti, Teresa Mosca, MariaRosaria Cammarota & Domenico Capone. (2017) Emerging Role of the Spleen in the Pharmacokinetics of Monoclonal Antibodies, Nanoparticles and Exosomes. International Journal of Molecular Sciences 18:6, pages 1249.
Crossref
Crossref
Sharif Abdelghany, Maha Alkhawaldeh & Hatim S. AlKhatib. (2017) Carrageenan-stabilized chitosan alginate nanoparticles loaded with ethionamide for the treatment of tuberculosis. Journal of Drug Delivery Science and Technology 39, pages 442-449.
Crossref
Crossref
Kanumuri Siva Rama Raju, Manoj Gundeti, Mohd Yaseen Malik, Naveen Kadian, Mamunur Rashid, Isha Taneja, Sheelendra Pratap Singh & Muhammad Wahajuddin. (2017) Bioanalysis of antitubercular drugs using liquid chromatography. Journal of Pharmaceutical and Biomedical Analysis 134, pages 295-309.
Crossref
Crossref
Lalit Kumar, Shivani Verma, Bhuvaneshwar Vaidya & Neelesh K. Mehra. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
293
324
.
Arunachalam Muthuraman & Jaspreet Kaur. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
139
167
.
Josef Jampílek & Katarína Král'ová. 2017. Nanostructures for Antimicrobial Therapy. Nanostructures for Antimicrobial Therapy
23
54
.
Juan Rodríguez-HernándezJuan Rodríguez-Hernández. 2017. Polymers against Microorganisms. Polymers against Microorganisms
71
93
.
Alejandro Sosnik. 2016. Handbook of Polyester Drug Delivery Systems. Handbook of Polyester Drug Delivery Systems
563
594
.
Hinojal Zazo, Clara I. Colino & José M. Lanao. (2016) Current applications of nanoparticles in infectious diseases. Journal of Controlled Release 224, pages 86-102.
Crossref
Crossref
. 2016. Controlled Release Systems. Controlled Release Systems
441
464
.
Anjuman Arora, Nusrat Shafiq, Sanjay Jain, G. K. Khuller, Sadhana Sharma & Samir Malhotra. (2015) Development of Sustained Release “NanoFDC (Fixed Dose Combination)” for Hypertension – An Experimental Study. PLOS ONE 10:6, pages e0128208.
Crossref
Crossref
Indu Pal Kaur & Harinder Singh. (2014) Nanostructured drug delivery for better management of tuberculosis. Journal of Controlled Release 184, pages 36-50.
Crossref
Crossref
Shelza Banyal, Parth Malik, Hardeep S. Tuli & Tapan K. Mukherjee. (2013) Advances in nanotechnology for diagnosis and treatment of tuberculosis. Current Opinion in Pulmonary Medicine 19:3, pages 289-297.
Crossref
Crossref
Peng-Li Li, Chun-Xia Li, Yi-Ting Xue, Hai-Hua Li, Hong-Bing Liu, Xiao-Xi He, Guang-Li Yu & Hua-Shi Guan. (2013) An HPLC Method for Microanalysis and Pharmacokinetics of Marine Sulfated Polysaccharide PSS-Loaded Poly Lactic-co-Glycolic Acid (PLGA) Nanoparticles in Rat Plasma. Marine Drugs 11:12, pages 1113-1125.
Crossref
Crossref
Li Wang, Yan-song Wang, Rong-ying Chen, Chun-lai Feng, Hao Wang, Xi-wen Zhu, Jiang-nan Yu & Xi-ming Xu. (2013) Plga Microspheres as a Delivery Vehicle for Sustained Release of Tetracycline: Biodistribution in Mice After Subcutaneous Administration. Journal of Drug Delivery Science and Technology 23:6, pages 547-553.
Crossref
Crossref
Emilie Roger, Stephen Kalscheuer, Ameya Kirtane, Bharath Raja Guru, Alex E. Grill, Judith Whittum-Hudson & Jayanth Panyam. (2012) Folic Acid Functionalized Nanoparticles for Enhanced Oral Drug Delivery. Molecular Pharmaceutics 9:7, pages 2103-2110.
Crossref
Crossref
Amanda C. Engler, Nikken Wiradharma, Zhan Yuin Ong, Daniel J. Coady, James L. Hedrick & Yi-Yan Yang. (2012) Emerging trends in macromolecular antimicrobials to fight multi-drug-resistant infections. Nano Today 7:3, pages 201-222.
Crossref
Crossref
Gaurav Kumar, Sadhna Sharma, Nusrat Shafiq, Gopal Krishan Khuller & Samir Malhotra. (2012) Optimization, in vitro–in vivo Evaluation, and Short-term Tolerability of Novel Levofloxacin-loaded PLGA Nanoparticle Formulation. Journal of Pharmaceutical Sciences 101:6, pages 2165-2176.
Crossref
Crossref
Rajesh Pandey & Zahoor Ahmad. (2011) Nanomedicine and experimental tuberculosis: facts, flaws, and future. Nanomedicine: Nanotechnology, Biology and Medicine 7:3, pages 259-272.
Crossref
Crossref